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Approximately 17% of the Scottish population lives in a remote or rural location. 
Current research is contradictory as to whether living a rural location leads to poorer 
outcomes or affects survival from colorectal cancer (CRC). We aimed to assess if 




A prospective single-centre observational study was conducted. All patients who 
underwent resection for colorectal cancer 2005-2016 in NHS Grampian were 
included. Patients were split into two groups for comparison (urban post-code vs 
rural) using the Scottish government two-tier classification system. Tumour location, 
one-year survival, lymph node involvement and extra-mural vascular invasion was 
recorded and compared between the groups. 
 
Results 
Of 2463 patients, 843 (34.2%) lived in a rural area. Rural patients were more likely to 
be detected through screening (17.4% versus 14.6%, p=0.04). There were no 
differences in pathology between rural and urban groups if detected through 
screening. However, rural patients detected through symptomatic pathways were 
more likely to be node positive p=0.015. On multivariable analysis, rurality did not 
independently predict for node positive presentation. Furthermore, there were no 
differences in cumulative survival between the two groups. 
 
Conclusion 
Although there were some differences in pathological characteristics between rural 
and urban patients, place of residence did not independently predict for outcome in 
this cohort.  Rurality had previously been shown to impact on outcome up to 20 
years ago. Improvements in infrastructure and rural healthcare may have influenced 
this change.  
 
Introduction 
Cure from colorectal cancer (CRC) is influenced by a many different characteristics. 
Tumours detected at an earlier stage have a significantly improved survival profile to 
those identified with local progression or distant spread. The one-year survival rate 
for stage one CRC is 98% versus only 40% for stage four. (Cancer research UK, 
2016 figures). The pathological factors influencing potential cure include extra-mural 
vascular invasion1, nodal status2, complete excision3 and location within the 
colorectum4. In addition, patient characteristics such as age5, co-morbidity6 and 
lifestyle choices7 influence outcome. However, it remains unclear if living in different 
regions of the country adversely influences the ability to survive a CRC diagnosis8-10. 
 
At present, environmental influences on cancer presentation and survival have been 
identified but their interactions are not fully established. The micro-environment in 
which the colon is exposed has been predicted to be responsible for the 
development of this disease11. Diet, pollutants and smoking status12 can change the 
epithelial environment and potentially cause neoplastic change. However, the macro-
environment in which an individual lives their daily lives may also have a role in 
cancer development and outcome. Individuals who live in an urban setting are 
exposed to more environmental carcinogens in their daily life than those living in 
more remote areas13. However, people living in an urban region may have easier 
access to healthcare services as they live closer to primary care practitioners and 
hospitals in comparison to rural patients. It is therefore possible that a patient’s place 
of residence (i.e. living in a rural vs urban location) may influence their potential to 
develop CRC, and their time to presentation once a malignancy has developed.  
 
Rurality has previously been associated with poorer survival of cancers (not defined 
into specific organs or body regions)9,14. Other analyses have shown that rurality 
may decrease the uptake of colorectal screening programmes15 but impair access to 
specialist care16.  However, these studies looked at American and Australian 
populations where patients live in far more remote locations than in the UK. 
Historical studies from the UK on the influence of rurality on cancer outcomes had 
demonstrated that living further away from a cancer centre did have an adverse 
effect on cancer outcome8. However, conflicting analysis reported reduced 
emergency admissions with CRC and an improved outcome in a rural cohort of 
patients in 1997-199810. There is little contemporary analysis of whether living in a 
rural region influences CRC presentation and outcome.   
 
Almost one million individuals in Scotland reside in remote and rural areas - 17.1% of 
the Scottish population17. Any disparity in presentation and outcome of people on the 
basis of their residence is therefore a substantial public health concern. Potentially 
high risk groups could be specifically targeted with education strategies and 
information. In this study we aim to analyse patients undergoing resection with 
curative intent for CRC in the NHS Grampian region (a single Scottish Health Board) 
to determine if living in rurally is associated with patient age at diagnosis, cancer 
stage, EMVI, nodal involvement, site of cancer or one-year survival following 
resection. 
Methods 
This is a prospective observational review in a single Scottish region. A prospectively 
maintained pathology database of all patients who had a colorectal cancer resected 
with curative intent between 2005 - 2016 at Aberdeen Royal Infirmary or Dr Gray’s 
Hospital, Elgin was analysed. These two hospitals are the secondary care facilities 
for NHS Grampian which covers an area of 8,700 km2, serves a total population of 
586,380 people. (June 2017, National Records for Scotland). 
Inclusion/ exclusion criteria 
All patients with a CRC diagnosed in the study time frame, undergoing surgical 
resection with curative intent and whose residential postcode was available at the 
time of analysis were included. Patients with non-resectable CRC cancer due to 
frailty, distant metastasis and/ or significant co-morbidities, those whose postcode 
was not available and those lost to follow-up were excluded.  
 
Definitions: measure of rurality and deprivation  
Individual residential postcodes were used to assign a rurality score for each patient 
using the Scottish Government Rurality Index17. Postcodes were collected from 
patient records and then input into the Scottish Information Services Division 
database (Information Services Division, Scotland) giving a score of 1-6 for each 
patient, defined in table 1. 
 
 
Patients were then grouped into two cohorts for analysis: urban = rurality score 1-4 
vs remote = rurality score 5 or 6 using the Scottish Government 2-fold classification 
system, as previously described17. Non-symptomatic patients (those detected via the 
bowel screening programme) and symptomatic patients were also compared. 
 
Deprivation was also calculated based on residential postcode. Deciles of the 
Scottish Index of Multiple Deprivation (SIMD) were assessed18.  
 
Site of cancer 
Cancer were defined as proximal (appendix, caecum, ascending colon, hepatic 
flexure, transverse colon), distal (splenic flexure, descending colon, sigmoid colon) 
or rectal depending on location within the colorectum.  
 
Outcomes 




All analysis was performed on SPSS v25 (IBM, New York). Categorical variables 
between rural and urban groups were assessed using the Chi squared test and 
?continuous variables by the Mann Whitney U test. Survival analysis was performed 
by Kaplan Meier tests. Multivariable analysis for Node positive predictors was 
performed by binary logistic regression. 
 
Ethical approval 
This project was registered with the Research Governance department of the 
University of Aberdeen. Caldicott approvals were obtained by NHS Grampian 
Caldicott guardian and the project was reviewed by IRAS proportionate ethical 
review (IRAS project number 264006). 
Results 
 
Of 2562 patients, 2463 had residential postcode data available and were included in 
the study (96.1%). The remaining patients were of no fixed abode or lived in another 
region of the country. The number of people who lived in an urban region was 1620 
(65.8%) region and 843 (34.2%) lived in a remote area. The median age of patients 
was younger in the rural group (70.5 years, IQR 62-78 Urban, and 69 years IQR 61-
76 Rural; p=0.013). More rural patients were male (urban region 53.1% male vs rural 
region 57.9% male, p = 0.027). The proportion of rural patients with a rectal cancer 
that received neoadjuvant therapy (either chemoradiotherapy or radiotherapy) was 
67.7% and it was 68.0% for the urban group, p=0.928. Interestingly, cancers 
detected through the national screening programme were 14.6% in the urban group 
and 17.4% in the rural group (p=0.04). Demographic data is summarised in table 2.  
 
Patients detected via the bowel screening programme were then compared to those 
detected via referral for symptoms, summarised in table 3. In the screen-detected 
group there was no statistically significant difference in site, stage, nodal involvement 
or EMVI between groups. In the symptomatic group (those tumours detected out with 
the screening programme) no difference was found in site, stage at presentation or 
EMVI. There was however a higher degree of nodal involvement in rural patients 




A multivariable analysis was then performed to determine if a rural residence 
independently predicted for nodal disease at presentation. Rurality was factored 
against screening status, gender, age and deprivation. In this model, only screening 
status was found to be independently predictive of node positive disease. (table 4). 
Median follow up of this cohort was 5 years. A Kaplan Meier curve was performed to 
analyse survival by urban or rural abode (figure 1) and this showed no difference in 






In this analysis, the first of its type to be performed after the establishment of the 
bowel screening programme in the United Kingdom, we have identified some 
differences in presentation of CRC by rural residence. Patients living in a rural region 
are more likely to have their CRC detected by screening. In addition, a greater 
proportion of rural CRC patients were male. Although rurality had no influence on 
pathological characteristics in the screening group, symptomatic patients were more 
likely to have nodal disease. However, this was not found to be independent of other 
factors and did not appear to influence survival up to five years post operation.  
 
Countries around the world have far more remote populations than Scotland: in the 
US and Australia patients may have to travel hundreds of kilometres for specialist 
treatment, particularly with the ongoing trend of centralisation of services.  An 
Australian study showed that patients with rectal cancers had on average a 6% 
increase in mortality risk (95% CI, 3%-8%; P < 0.001) per 100km distance that they 
lived from a radiotherapy treatment centre19.  Globally, rural dwellers were found to 
be 5% less likely to survive cancer when compared to their urban counterparts14. It is 
difficult to interpret these results in a smaller country with comparatively shorter 
distances to cancer centres such as those found in the UK.  
 
In previous analysis of UK data, Campbell et al found that remote CRC patients were 
more likely to present and die as an emergency cases than urban patients. Rural 
patients, after diagnosis, had a small survival disadvantage with increasing 
distance8. Previous quantitative work 15 years ago found that delayed treatment 
appeared to be more common in the rural population20. However each of these 
studies were conducted before the introduction of the Scottish Referral Guidelines 
for Suspected Cancer in 2002 and also before the bowel screening programme was 
widely introduced in the region (pilot commenced in 2006).  A more recent qualitative 
study in 2018 had similar findings, suggesting attitudes amongst the rural population 
have not changed21.  
 
Our analysis adds to previous analysis in this field that has been conflicting in nature. 
In a study of eight cancers (with CRC making up 22.5% of total cases) patients with 
a journey of more than an hour to the cancer treatment centre were diagnosed more 
quickly and were more likely to receive treatment within the recommended time but 
despite this still had an increased mortality at one  year following GP referral9. In 
contrast, Murage et al found that rural patients with CRC in North East Scotland 
1997-1998 had improved three year survival when compared with the urban 
population despite longer travel times to their nearest GP surgery10. In 2008 the 
Scottish Government published it’s ‘Delivering for Remote and Rural Healthcare’ 
report, with specific points on improving access to secondary care, infrastructure and 
emergency response and transport in rural areas. Our study suggests these 
interventions, alongside the introduction of the CRC screening programme have 
been effective with regard to CRC in this region. Improved health awareness in the 
rural community or better infrastructure may also influence this change in outcome. 
However, the specific reasons why such improvements are seen are beyond the 
scope of this analysis.  
 
Our observation of a higher rate of screened detected cancers in rural patients is 
interesting, since the impact of rurality on cancer-screening uptake has received 
relatively little attention generally in contrast to the effects of deprivation. Against the 
context of evidence from Australia that rural patients were less likely to attend for 
breast screening, a study comparing breast cancer screening uptake in Rural 
Australia and Scotland was published in 201522 and concluded, against expectation, 
that rural women were not less likely to attend for breast screening in either country. 
The issue has been largely unexplored in CRC screening so our findings are novel, 
interesting and should prompt further investigation.  
 
The study has a number of strengths. It is based on a comprehensive database with 
12 years of data for patients covering all of NHS Grampian. However, the nature of 
the study means that it is dependent on the accuracy of data recorded at the time. 
More than 95% of cases had an available postcode in this study, reducing the risk of 
bias. 
 
The measure of deprivation was based on area rather than the individual which 
could affect the result. Access to public transport and variation in individual GP 
referral times or rates were not assessed.  Furthermore, unfortunately it was not 
possible to compare specific physiological differences between patients in the rural 
vs urban groups such as BMI, frailty and co-morbid conditions, all factors which may 
affect survival and outcomes, as these were not available in this dataset. In addition, 
this study population only included patients with resectable CRC operated on 
primarily with curative intent: patients with inoperable disease were excluded from 
the study therefore it has not been possible to compare this group of patients in the 
rural and urban areas. This would be an interesting area for future research as it 
would be useful to determine if there are any difference in stage IV cases between 
the rural and urban groups and also whether there is a difference in the number of 
patients in each group who are deemed unsuitable for surgery due to frailty or 
significant co-morbidities.  
 
Conclusion 
This study found no difference in cumulative survival for CRC patients living in more 
remote areas of the North-East Scotland when compared to patients living in urban 
areas when analysed over a median follow up period of five years. Patients from a 
rural region, when controlling for other factors had the same stage of cancer on 
resection. Our contemporary analysis of the influence of rurality of CRC outcomes 
show different results to historical papers and suggest that the rural population are 
no longer adversely affected in the management of CRC. Interestingly however, rural 
CRC patients are more likely to come from the national screening programme and 
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Class Class Name Definition 
1 Large Urban Area Settlements of 125,000 people and over.  
2 Accessible Urban Settlements of 10,000 to 124,999 people. 
3 Accessible Small Town Settlements of 3,000 to 9,999 people, and within a 30 minute 
drive time of a Settlement of 10,000 or more.  
4 Remote Small Town Settlements of 3,000 to 9,999 people, and with a drive time of 
over 30 minutes to a Settlement of 10,000 or more. 
5 Accessible Rural Areas with a population of less than 3,000 people, and within a 
30 minute drive time of a Settlement of 10,000 or more.  
6 Remote and Rural Areas with a population of less than 3,000 people, and with a 
drive time of over 30 minutes to a Settlement of 10,000 or 
more.  
 
 Table 1: Scottish Government Urban Rural Classification Categories 2016.  
 
Table 2: Patient demographic, 2005-2016. 
 
 Urban Remote P value 
Number of patients 1620 843 n/a 
Female: Male (%) 759:861  
(46.9% : 53.1%) 
355: 488 
(42.1% : 57.9%) 
0.027 
Age: Median (IQR) 70.5 (62-78) 69 (61-76) 0.031 
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Table 3: Pathological characteristics by screening status. 
Table 4: Multivariate Analysis for Predicting Nodal Disease 
 
 




















































Figure 1: Survival analysis 
  
 
 
